-
July 16, 2014 Lupin Receives the 2014 ASTD BEST Award for Learning & Development
-
June 13, 2014 Lupin Launches Generic Cipro® for Oral Suspension in the US
-
May 7, 2014 Quarter IV & Annual Results, FY 2013-14 – Record Sales and Profits
-
April 23, 2014 Lupin Inks Strategic Joint Venture Agreement with Yoshindo Inc.
-
April 21, 2014 Lupin Appoints Theresa Stevens as Chief Corporate Development Officer.
-
April 9, 2014 Lupin Receives FDA Approval for Generic Actos® Tablets.
-
March 27, 2014 Lupin Acquires Laboratorios Grin S.A. De C.V., Mexico; Specialty Ophthalmic Company; Enters the Latin American Market.
-
March 21, 2014 Lupin launches Generic Niaspan® Tablets in the US
-
March 6, 2014 Lupin Receives FDA Approval for Generic Monodox® Capsules and Cipro® for Oral Suspension
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications